Lv1
30 积分 2025-09-10 加入
Migraine understood as a sensory threshold disease
1个月前
已完结
BOLD repetition enhancement in the orbitofrontal cortex during complex visuospatial processing in migraine without aura: a shift in periaqueductal gray - cortical coupling?
1个月前
已完结
Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
1个月前
已完结
Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial
1个月前
已完结
CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention
1个月前
已完结
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine
1个月前
已完结
Constipation as a possible predictor of poor treatment response in chronic migraine: A retrospective study of anti-CGRP monoclonal antibodies
1个月前
已完结
Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
1个月前
已完结
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
1个月前
已完结
A phase 4, randomized, double-blind, placebo-controlled trial evaluating the efficacy and tolerability of rimegepant for the prevention of episodic migraine in adults with a history of inadequate response to traditional oral preventive medications
4个月前
已完结
皖公网安备34019202002308
